MEGAN GROSSMAN: Open Payments
NPI 1376027235 · CAMARILLO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 27 payments from 15 companies in 2025. Trend: 2023 $608 · 2024 $1,224 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 3 | $74 |
| ABBVIE INC. | 4 | $73 |
| Journey Medical Corporation | 3 | $72 |
| Incyte Corporation | 3 | $65 |
| GENZYME CORPORATION | 2 | $63 |
| Lilly USA, LLC | 2 | $50 |
| Amgen Inc. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| PFIZER INC. | 1 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
Products named: DUPIXENT, SKYRIZI, OPZELURA, ADBRY, TALTZ, OTEZLA, COSENTYX, CIBINQO.
Industry payments across CA — which companies pay providers there.
